{
  "DOI": "10.1007/s00439-020-02218-3",
  "ISSN": [
    "0340-6717",
    "1432-1203"
  ],
  "URL": "http://dx.doi.org/10.1007/s00439-020-02218-3",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eIn recent years, large efforts have been made to unravel the role of the gut microbiota in inflammatory bowel disease (IBD), which is a chronic inflammatory disorder of the gastro-intestinal tract. Considering the heterogeneity patients with IBD display in their disease course and response to treatment, there is a big need in translating these findings towards clinical practise. In this perspective article, we discuss strategies to facilitate the transition from basic science on gut microbiota in IBD to clinical applications. We suggest that setting gold standards, improving and increasing the biobanking efforts, and studying other members of the gut microbiota are a necessary step to reveal the exact role of the gut microbiota in IBD. In addition, we discuss the potential of the gut microbiome as a clinical tool for the diagnoses, prediction and/or treatment of the disease. We believe that the growing interest in the gut microbiota will reveal its potential in the management of IBD in a not too distant future.\u003c/jats:p\u003e",
  "alternative-id": [
    "2218"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "28 May 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "16 August 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "28 August 2020"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare that they have no conflict of interest."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0003-3743-1544",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Collij",
      "given": "Valerie",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Klaassen",
      "given": "Marjolein A. Y.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Weersma",
      "given": "Rinse K.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Vila",
      "given": "Arnau Vich",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2020,
        8,
        28
      ]
    ],
    "date-time": "2020-08-28T15:03:56Z",
    "timestamp": 1598627036000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        8,
        27
      ]
    ],
    "date-time": "2021-08-27T23:54:17Z",
    "timestamp": 1630108457000
  },
  "indexed": {
    "date-parts": [
      [
        2022,
        6,
        19
      ]
    ],
    "date-time": "2022-06-19T15:28:14Z",
    "timestamp": 1655652494737
  },
  "is-referenced-by-count": 4,
  "issn-type": [
    {
      "type": "print",
      "value": "0340-6717"
    },
    {
      "type": "electronic",
      "value": "1432-1203"
    }
  ],
  "issue": "5",
  "issued": {
    "date-parts": [
      [
        2020,
        8,
        28
      ]
    ]
  },
  "journal-issue": {
    "issue": "5",
    "published-print": {
      "date-parts": [
        [
          2021,
          5
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            8,
            28
          ]
        ],
        "date-time": "2020-08-28T00:00:00Z",
        "timestamp": 1598572800000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            8,
            28
          ]
        ],
        "date-time": "2020-08-28T00:00:00Z",
        "timestamp": 1598572800000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s00439-020-02218-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s00439-020-02218-3/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s00439-020-02218-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "703-708",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2020,
        8,
        28
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2020,
        8,
        28
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2021,
        5
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.5582/ddt.2019.01000",
      "author": "W Akram",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Drug Discov Ther",
      "key": "2218_CR1",
      "unstructured": "Akram W, Garud N, Joshi R (2019) Role of inulin as prebiotics on inflammatory bowel disease. Drug Discov Ther 13:1–8",
      "volume": "13",
      "year": "2019"
    },
    {
      "DOI": "10.1016/S0140-6736(19)31266-8",
      "author": "JR Allegretti",
      "doi-asserted-by": "publisher",
      "first-page": "420",
      "journal-title": "Lancet",
      "key": "2218_CR2",
      "unstructured": "Allegretti JR, Mullish BH, Kelly C, Fischer M (2019) The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications. Lancet 394:420–431",
      "volume": "394",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.chom.2017.04.010",
      "author": "AN Ananthakrishnan",
      "doi-asserted-by": "publisher",
      "first-page": "603",
      "journal-title": "Cell Host Microbe",
      "key": "2218_CR3",
      "unstructured": "Ananthakrishnan AN, Luo C, Yajnik V, Khalili H, Garber JJ, Stevens BW, Cleland T, Xavier RJ (2017) Gut microbiome function predicts response to anti-integrin biologic therapy in inflammatory bowel disease. Cell Host Microbe 21:603–610",
      "volume": "21",
      "year": "2017"
    },
    {
      "DOI": "10.1097/MCG.0b013e31828b2196",
      "author": "F Bennebroek-Evertsz’",
      "doi-asserted-by": "publisher",
      "first-page": "850",
      "journal-title": "J Clin Gastroenterol",
      "key": "2218_CR4",
      "unstructured": "Bennebroek-Evertsz’ F, Hoeks CCMQ, Nieuwkerk PT, Stokkers PCF, Ponsioen CY, Bockting CLH, Sanderman R, Sprangers MAG (2013) Development of the patient harvey bradshaw index and a comparison with a clinician-based harvey bradshaw index assessment of Crohn’s disease activity. J Clin Gastroenterol 47:850–856",
      "volume": "47",
      "year": "2013"
    },
    {
      "key": "2218_CR5",
      "unstructured": "Finch Therapeutics. https://finchtherapeutics.com/fin524. Accessed Nov 2019"
    },
    {
      "DOI": "10.1126/science.aan4236",
      "author": "V Gopalakrishnan",
      "doi-asserted-by": "publisher",
      "first-page": "97",
      "journal-title": "Science",
      "key": "2218_CR6",
      "unstructured": "Gopalakrishnan V, Spencer CN, Nezi L et al (2018) Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359:97–103",
      "volume": "359",
      "year": "2018"
    },
    {
      "DOI": "10.1038/nature11209",
      "author": "Human Microbiome Project Consortium",
      "doi-asserted-by": "publisher",
      "first-page": "215",
      "journal-title": "Nature",
      "key": "2218_CR7",
      "unstructured": "Human Microbiome Project Consortium (2012) A framework for human microbiome research. Nature 486:215–221",
      "volume": "486",
      "year": "2012"
    },
    {
      "DOI": "10.1186/s12876-018-0917-5",
      "author": "F Imhann",
      "doi-asserted-by": "publisher",
      "first-page": "5",
      "journal-title": "BMC Gastroenterol",
      "key": "2218_CR8",
      "unstructured": "Imhann F, Van der Velde KJ, Barbieri R, Alberts R, Voskuil MD, Vich Vila A, Collij V, Spekhorst LM, Van der Sloot KWJ, Peters V, Van Dullemen HM, Visschedijk MC, Festen EAM, Swertz MA, Dijkstra G, Weersma RK (1000IBD) The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1. BMC Gastroenterol 19:5",
      "volume": "19",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41467-019-13036-1",
      "author": "JS Johnson",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Nat Commun",
      "key": "2218_CR9",
      "unstructured": "Johnson JS, Spakowicz DJ, Hong BY, Petersen LM, Demkowicz P, Chen L, Leopold SR, Hanson BM, Agresta HO, Gerstein M, Sodergren E, Weinstock GM (2019) Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis. Nat Commun 10:1–11",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.1038/nature11582",
      "author": "L Jostins",
      "doi-asserted-by": "publisher",
      "first-page": "119",
      "journal-title": "Nature",
      "key": "2218_CR10",
      "unstructured": "Jostins L, Ripke S, Weersma RK et al (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491:119–124",
      "volume": "491",
      "year": "2012"
    },
    {
      "DOI": "10.1136/gutjnl-2019-319505",
      "author": "H Khalili",
      "doi-asserted-by": "publisher",
      "journal-title": "Gut",
      "key": "2218_CR11",
      "unstructured": "Khalili H, Håkansson N, Chan SS, Chen Y, Lochhead P, Ludvigsson JF, Chan AT, Hart AR, Olén O, Wolk A (2020) Adherence to a mediterranean diet is associated with a lower risk of later-onset Crohn's disease: results from two large prospective cohort studies. Gut. https://doi.org/10.1136/gutjnl-2019-319505",
      "year": "2020"
    },
    {
      "DOI": "10.1093/ecco-jcc/jjz077",
      "author": "MAY Klaassen",
      "doi-asserted-by": "publisher",
      "first-page": "1439",
      "journal-title": "J Crohns Colitis",
      "key": "2218_CR12",
      "unstructured": "Klaassen MAY, Imhann F, Collij V, Fu J, Wijmenga C, Zhernakova A, Dijkstra G, Festen EAM, Gacesa R, Vich Vila A, Weersma RK (2019) Anti-inflammatory gut microbial pathways are decreased during Crohn's disease exacerbations. J Crohns Colitis 13:1439–1449",
      "volume": "13",
      "year": "2019"
    },
    {
      "DOI": "10.1136/gutjnl-2011-301805",
      "author": "P Lepage",
      "doi-asserted-by": "publisher",
      "first-page": "146",
      "journal-title": "Gut",
      "key": "2218_CR13",
      "unstructured": "Lepage P, Leclerc MC, Joossens M, Mondot S, Blottière HM, Raes J, Ehrlich D, Doré J (2013) A metagenomic insight into our gut’s microbiome. Gut 62:146–158",
      "volume": "62",
      "year": "2013"
    },
    {
      "DOI": "10.1056/NEJMra1600266",
      "author": "SV Lynch",
      "doi-asserted-by": "publisher",
      "first-page": "2369",
      "journal-title": "N Engl J Med",
      "key": "2218_CR14",
      "unstructured": "Lynch SV, Pedersen O (2016) The human intestinal microbiome in health and disease. N Engl J Med 375:2369–2379",
      "volume": "375",
      "year": "2016"
    },
    {
      "DOI": "10.1177/2050640619836057",
      "author": "R Moerkens",
      "doi-asserted-by": "publisher",
      "first-page": "467",
      "journal-title": "United Eur Gastroenterol J",
      "key": "2218_CR15",
      "unstructured": "Moerkens R, Mooiweer J, Withoff S, Wijmenga C (2019) Celiac disease-on-chip: modeling a multifactorial disease in vitro. United Eur Gastroenterol J 7:467–476",
      "volume": "7",
      "year": "2019"
    },
    {
      "DOI": "10.1186/s12866-019-1519-2",
      "author": "S Moossavi",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "BMC Microbiol",
      "key": "2218_CR16",
      "unstructured": "Moossavi S, Engen PA, Ghanbari R, Green SJ, Naqib A, Bishehsari F, Merat S, Poustchi H, Keshavarzian A, Malekzadeh R (2019) Assessment of the impact of different fecal storage protocols on the microbiota diversity and composition: a pilot study. BMC Microbiol 19:1–8",
      "volume": "19",
      "year": "2019"
    },
    {
      "DOI": "10.1038/nrgastro.2017.88",
      "author": "J Ni",
      "doi-asserted-by": "publisher",
      "first-page": "573",
      "journal-title": "Nat Rev Gastroenterol Hepatol",
      "key": "2218_CR17",
      "unstructured": "Ni J, Wu GD, Albenberg L, Tomov VT (2017) Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol 14:573–584",
      "volume": "14",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.cell.2015.01.002",
      "author": "JM Norman",
      "doi-asserted-by": "publisher",
      "first-page": "447",
      "journal-title": "Cell",
      "key": "2218_CR18",
      "unstructured": "Norman JM, Handley SA, Baldridge MT, Droit L, Liu CY, Keller BC, Kambal A, Monaco CL, Zhao G, Fleshner P, Stappenbeck TS, McGovern DPB, Keshavarzian A, Mutlu EA, Sauk J, Gevers D, Xavier RJ, Wang D, Parkes M, Virgin HW (2015) Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 160:447–460",
      "volume": "160",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.cell.2019.01.001",
      "author": "E Pasolli",
      "doi-asserted-by": "publisher",
      "first-page": "649",
      "journal-title": "Cell",
      "key": "2218_CR19",
      "unstructured": "Pasolli E, Asnicar F, Manara S, Zolfo M, Karcher N, Armanini F, Beghini F, Manghi P, Tett A, Ghensi P, Collado MC, Rice BL, DuLong C, Morgan XC, Golden CD, Quince C, Huttenhower C, Segata N (2019) Extensive unexplored human microbiome diversity revealed by over 150,000 genomes from metagenomes spanning age, geography, and lifestyle. Cell 17:649–662",
      "volume": "17",
      "year": "2019"
    },
    {
      "DOI": "10.1038/nmeth.4458",
      "author": "A Sczyrba",
      "doi-asserted-by": "publisher",
      "first-page": "1063",
      "journal-title": "Nat Methods",
      "key": "2218_CR20",
      "unstructured": "Sczyrba A, Hofmann P, Belmann P et al (2017) Critical assessment of metagenome interpretation-a benchmark of metagenomics software. Nat Methods 14:1063–1071",
      "volume": "14",
      "year": "2017"
    },
    {
      "DOI": "10.1128/IAI.66.11.5224-5231.1998",
      "author": "RK Sellon",
      "doi-asserted-by": "publisher",
      "first-page": "5224",
      "journal-title": "Infect Immun",
      "key": "2218_CR21",
      "unstructured": "Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, Rennick DM, Sartor RB (1998) Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66:5224–5231",
      "volume": "66",
      "year": "1998"
    },
    {
      "DOI": "10.1053/j.gastro.2018.12.002",
      "author": "V Svolos",
      "doi-asserted-by": "publisher",
      "first-page": "1354",
      "journal-title": "Gastroenterology",
      "key": "2218_CR22",
      "unstructured": "Svolos V, Hansen R, Nichols B, Quince C, Ijaz UZ, Papadopoulou RT, Edwards CA, Watson D, Alghamdi A, Brejnrod A, Ansalone C, Duncan H, Gervais L, Tayler R, Salmond J, Bolognini D, Klopfleisch R, Gaya DR, Milling S, Russell RK, Gerasimidis K (2019) Treatment of active Crohn's disease with an ordinary food-based diet that replicates exclusive enteral nutrition. Gastroenterology 156:1354–1367",
      "volume": "156",
      "year": "2019"
    },
    {
      "DOI": "10.1016/S0140-6736(16)31711-1",
      "author": "J Torres",
      "doi-asserted-by": "publisher",
      "first-page": "1741",
      "journal-title": "Lancet",
      "key": "2218_CR23",
      "unstructured": "Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L (2017) Crohn’s disease. Lancet 389:1741–1755",
      "volume": "389",
      "year": "2017"
    },
    {
      "DOI": "10.1136/gutjnl-2018-317855",
      "author": "J Torres",
      "doi-asserted-by": "publisher",
      "first-page": "42",
      "journal-title": "Gut",
      "key": "2218_CR24",
      "unstructured": "Torres J, Hu J, Seki A, Eisele C, Nair N, Huang R, Tarassishin L, Jharap B, Cote-Daigneault J, Mao Q, Mogno I, Britton GJ, Uzzan M, Chen CL, Kornbluth A, George J, Legnani P, Maser E, Loudon H, Stone J, Dubinsky M, Faith JJ, Clemente JC, Mehandru S, Colombel JF, Peter I (2020) Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice. Gut 69:42–51",
      "volume": "69",
      "year": "2020"
    },
    {
      "DOI": "10.1016/S0140-6736(16)32126-2",
      "author": "R Ungaro",
      "doi-asserted-by": "publisher",
      "first-page": "1756",
      "journal-title": "Lancet",
      "key": "2218_CR25",
      "unstructured": "Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF (2017) Ulcerative colitis. Lancet 389:1756–1770",
      "volume": "389",
      "year": "2017"
    },
    {
      "key": "2218_CR26",
      "unstructured": "Vedanta Biosciences. https://www.vedantabio.com/pipeline/ve202. Accessed Nov 2019"
    },
    {
      "DOI": "10.1126/scitranslmed.aap8914",
      "author": "A Vich Vila",
      "doi-asserted-by": "publisher",
      "first-page": "eaap8914",
      "journal-title": "Sci Transl Med",
      "key": "2218_CR27",
      "unstructured": "Vich Vila A, Imhann F, Collij V, Jankipersadsing SA, Gurry T, Mujagic Z, Kurilshikov A, Bonder MJ, Jiang X, Tigchelaar EF, Dekens J, Peters V, Voskuil MD, Visschedijk MC, van Dullemen HM, Keszthelyi D, Swertz MA, Franke L, Alberts R, Festen EAM, Dijkstra G, Masclee AAM, Hofker MH, Xavier RJ, Alm EJ, Fu J, Wijmenga C, Jonkers DMAE, Zhernakova A, Weersma RK (2018) Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Sci Transl Med 10:eaap8914",
      "volume": "10",
      "year": "2018"
    },
    {
      "DOI": "10.1136/gut.43.1.29",
      "author": "RS Walmsley",
      "doi-asserted-by": "publisher",
      "first-page": "29",
      "journal-title": "Gut",
      "key": "2218_CR28",
      "unstructured": "Walmsley RS, Ayres RCS, Pounder RE, Allan RN (1998) A simple clinical colitis activity index. Gut 43:29–32",
      "volume": "43",
      "year": "1998"
    },
    {
      "DOI": "10.1136/gutjnl-2019-320204",
      "author": "RK Weersma",
      "doi-asserted-by": "publisher",
      "journal-title": "Gut",
      "key": "2218_CR29",
      "unstructured": "Weersma RK, Zhernakova A, Fu J (2020) Interaction between drugs and the gut microbiome. Gut. https://doi.org/10.1136/gutjnl-2019-320204",
      "year": "2020"
    },
    {
      "DOI": "10.1126/science.aad3369",
      "author": "A Zhernakova",
      "doi-asserted-by": "publisher",
      "first-page": "565",
      "journal-title": "Science",
      "key": "2218_CR30",
      "unstructured": "Zhernakova A, Kurilshikov A, Bonder MJ, Tigchelaar EF, Schirmer M, Vatanen T, Mujagic Z, Vich Vila A, Falony G, Vieira-Silva S, Wang J, Imhann F, Brandsma E, Jankipersadsing SA, Joossens M, Cenit MC, Deelen P, Swertz MA, LifeLines cohort study, Weersma RK, Feskens EJM, Netea MG, Gevers D, Jonkers D, Franke L, Aulchenko YS, Huttenhower C, Raes J, Hofker MH, Xavier RJ, Wijmenga C, Fu J (2016) Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352:565–569",
      "volume": "352",
      "year": "2016"
    }
  ],
  "reference-count": 30,
  "references-count": 30,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s00439-020-02218-3"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Gut microbiota in inflammatory bowel diseases: moving from basic science to clinical applications"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "140"
}